Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,025 public trials 2,027 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma

NCT02594384

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Winship Cancer Institute at Emory University Atlanta, Georgia, United States
  • Horizon Oncology Research, Inc. Lafayette, Indiana, United States
View Trial Details
Completed

Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma

NCT03110562

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Boca Raton Clinical Research (BRCR) Medical Center Plantation, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Kaiser Permanente Hawaii Honolulu, Hawaii, United States
  • McFarland Clinic Ames, Iowa, United States
View all 157 locations
View Trial Details
Completed

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

NCT04450069

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details

Related conditions